“We’re dedicated to delivering the best genetics and technology for growers with the Credenz soybean seed,” said Monty Malone, elite performance trials lead for Bayer. “With this new station, we can continue to research, develop and provide innovative products that address the growing need for smart seed traits to safeguard and strengthen a crop that is increasingly valuable to growers across the globe.”
The Champaign facility is one of three soybean research stations Bayer will open in 2017. The stations are part of a three-year, $1 billion commitment from Bayer to invest in new research facilities, expansions and renovations across the United States. According to Bayer, the soybean breeding program at the MFTS will develop maturity group (MG) two and three Credenz seed, covering production areas in the Eastern Corn Belt. The four-building, 28,000-square-foot facility features space to accommodate a large-scale breeding program to develop top performing soybean products across Illinois and the Midwest.
“The time and resources Bayer is putting into this research not only shows our commitment to high-quality, high-yielding products, but also to our growers and the future of agriculture as a whole,” said Allen Gent, Bayer strategic business lead for seeds. “This station will bring together significant scientific resources to support the advancement of the agriculture industry.”
Bayer said it plans to expand the Credenz platform by introducing new trait technologies and working collaboratively with industry partners.
“Credenz offers an entirely new approach to soybean protection, focused on smart genetics and increased grower choice,” Gent said.
